Eli Lilly cuts insulin prices up to 70% amid federal pressure to lower costs

Source: USA Today

“Eli Lilly and Co. said it will cut prices of its most commonly prescribed insulins up to 70% and expand a program that limits out-of-pocket monthly costs for some consumers. The Indianapolis drugmaker’s price cuts and discounts for insulin come as federal and state lawmakers and patient advocates pressure drug companies and health insurers to improve affordability for the life-saving medication used by millions of Americans. … Lilly said in a news release that it will cap out-of-pocket costs for privately-insured consumers at $35 per month at the ‘majority of retail pharmacies.’ Company officials said about 85% of national and local pharmacies will honor the $35 price cap, but the company did not provide a list.” (03/01/23)